Basic Information
| LncRNA/CircRNA Name | circAGFG1 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | RNA-seq, qPCR, luciferase reporter assay |
| Sample | TNBC tissues |
| Expression Pattern | up-regulated |
| Function Description | We found that circAGFG1 was evidently up-regulated in TNBC, and its level was correlated with clinical stage, pathological grade and poor prognosis of patients with TNBC. |
| Pubmed ID | 30621700 |
| Year | 2018 |
| Title | The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. |
External Links
| Links for circAGFG1 | GenBank HGNC NONCODE |
| Links for breast cancer | OMIM COSMIC |